Overall, the recall includes 7,799 blood tests intended to help physicians identify early signs of a myocardial infarction. 

Researchers tracked data from nearly 38,000 obese patients who underwent TAVR or SAVR, sharing their findings in a new meta-analysis. 

The new 44-page document focuses on the detection, classification and risk assessment of congenital heart issues.

CMS also floated the idea of pausing the AUC program until a better implementation strategy could be put into place. 

Versanis, founded in 2021 by a venture capital firm, is primarily known as the company behind the obesity drug bimagrumab.

Echocardiography expert Roberto Lang, MD, says artificial intelligence will be so important to cardiac ultrasound in the near future that echo labs not using it will be inefficient and less accurate than labs that do use it.

Researchers think this new technique could be beneficial for patients presenting with both severe symptomatic aortic stenosis and chronic kidney disease. 

RoyalVibe Health offers direct-to-consumer scanners purported for multiple medical uses, which have not been reviewed or cleared by the agency.  

The program leverages the in-context learning abilities of large language models to generate report summaries using domain-specific, individualized data relative to radiology.